-- French drugmaker Sanofi-Aventis SA said Monday it plans to...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
PHARMACEUTICALS COMPANIES
The phrase "Big Pharma" is often used to refer to pharmaceutical companies with revenue in excess of $3 billion, and/or R&D expenditures in excess of $500 million. It is these pharmaceutical companies that are shaping the future of medicine. This topic covers the latest news and views on the companies behind the pharmaceuticals
10 largest are Johnson and Johnson, Pfizer, Bayer, GlaxoSmithKline, Novartis, Sanofi-Aventis, Hoffmann-La Roche, Astra Zeneca, Merck & Co., Abbott Laboratories.
Pharmaceuticals Companies is part of Business Exchange, suggested by
Henri TCHEN.
This topic contains
3,167 news
and
3,371 blog
items.
Read updated news, blogs, and resources about Pharmaceuticals Companies. Find user-submitted articles and reactions on Pharmaceuticals Companies from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
Each year we come out with a list of companies who should get rid of their CEOs or which should make some strategic...
Marvelle Sullivan, the head of corporate legal M&A at Novartis AG (NYSE:NVS), spoke at The Deal Economy 2010...
molecule type analysis 20 PharmaVitae Universe M&A analysis 23 PharmaVitae Universe operating performance analysis...
Pfizer Inc. (NYSE:PFE) employees concerned about their jobs may have a better idea of where they stand.
Johnson & Johnson (NYSE:JNJ), the world's biggest healthcare company that's been squeezed by generic competition,...
Once a powerful profit-machine, big pharma is stumbling ,the threat of further government intervention, drying product...
When Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) bought Proteolix Inc. on Oct. 12, (The Deal Pipeline subscription...
Merck's decision to acquire Schering-Plough (SGP) for $41 billion will improve its bottom line over the next two to...
Major trends with potentially far-reaching consequences for Big Pharma are underway that will likely influence drug...
Threat of a pandemic triggered by a new swine flu strain will provide a windfall for some makers of drugs and vaccines.
Since winning The Deal's Most Admired Corporate Dealmaker award in the healthcare category in 2008, Abbott Laboratories...
WSJ.com is available in the following editions and languages:
The race to offer H1N1 flu vaccination is picking up pace. While global H1N1 vaccine manufacturers like Sanofi Pasteur,...
We're tracking a subsector that's been hot with dealmaking -- oncology.
Cash starved companies are going to ... of bureaucratic big pharma processes that slow drug
The Royal College of Physicians is calling for an end to a 'culture' of doctors receiving freebies from pharmaceutical...
On Wednesday, Pfizer Inc. (NYSE:PFE) received approval from the FTC for its $68 billion acquisition of Wyeth.
AcelRx Pharmaceuticals has a handful of mid- and late-state clinical products in development, which would make this a...
Two days after Merck & Co announced a major push into generic versions of biotechnology medicines, Eli Lilly and Co...
Oncology deals keep coming. A week and a half after Sanofi-Aventis SA (NYSE:SNY) acquired the rights to sell an...
The swine flu outbreak is likely to benefit Kleiner Perkins Caufield & Byers because of the firm's portfolio of...
growth and evolve our business to compete effectively in what is a rapidly changing and challenging environment for...
Biopharmaceutical manufacturing is likely to undergo a dramatic change over the next 20 years, with the today's...
Deal would make Merck the second-biggest U.S. drugmaker, reports Bloomberg
Top Sources: Pharmaceuticals Companies
- 247wallst.com
- Reuters
- BusinessWeek
- online.wsj.com
- World of DTC Marketing
- International Herald Tribune
- Mail Online UK
- New York Times
- industry.bnet.com
- phrma.org
account